CCI clears Ranjan Pai’s investment in PharmEasyRanjan Pai invests in PharmEasy's funding with 360 One. API Holdings board seats acquired. Rights issue resolves debt. Monthly burn reducti...
26 Mar, 2024, 08.08 PM IST
PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsPai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...
01 Nov, 2023, 09.12 AM IST
ETtech Explainer: What are down rounds and will they become the norm for Indian startups?A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.
11 Jul, 2023, 05.27 PM IST
PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
08 Jul, 2023, 07.41 PM IST
PharmEasy parent seeks shareholder nod to increase authorised share capitalThe board notified its shareholders about increasing the authorised share capital to Rs 3,500 crore (about $423.72 million), divided into 3...
07 Jul, 2023, 10.59 PM IST
Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanMumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021
06 Jul, 2023, 11.42 PM IST
PharmEasy logs first ebitda profit of Rs 14 crore in April, restarts funding talksThe epharmacy held discussions with CDPQ, ADQ; convertible notes are also being discussed amid valuation corrections and markdowns.
15 May, 2023, 09.42 AM IST
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
14 Feb, 2023, 02.56 PM IST
PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
14 Sep, 2022, 09.28 AM IST
PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
22 Aug, 2022, 06.00 AM IST
Sebi clears PharmEasy’s Rs 6,250 crore IPOMumbai-based API Holdings had filed its draft IPO papers in November to raise Rs 6,250 crore through a sale of primary shares. Existing sha...
22 Feb, 2022, 09.13 AM IST
PharmEasy parent company gets Sebi nod for Rs 6,250-cr public offerAPI Holdings, the parent firm of PharmEasy, has got clearance from markets regulator Securities and Exchange Board of India for the online ...
22 Feb, 2022, 06.14 AM IST
Tata-owned 1mg, PharmEasy go offline for omnichannel presenceTata-owned 1mg is set to open its first physical store in Gurugram next month while rival PharmEasy has started to expand across the offlin...
30 Nov, 2021, 06.18 AM IST
Exclusive: New investors in talks to join PharmEasy’s pre-IPO funding roundThe company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder N...
04 Oct, 2021, 06.15 PM IST
Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
14 Sep, 2021, 06.00 AM IST
PharmEasy parent API Holdings strengthens board ahead of IPOAPI Holdings — the parent company of PharmEasy — has appointed five independent directors to its board. India's biggest online pharmacy is ...
13 Sep, 2021, 07.03 PM IST
PharmEasy in investment talks with Naspers, TPGOnline pharmacies such as PharmEasy and 1mg have registered growth outside their core metropolitan markets by rapidly expanding into tier-2...
09 Oct, 2020, 07.56 AM IST